TipRanks
Go Ultimate55% OFF

JAMES V CARUSO Insider Profile

4 Followers

JAMES V CARUSO, President & CEO, Director at Cellectar Biosciences, holds 20.32K shares in Cellectar Biosciences (Ticker: CLRB). Most recently, JAMES V CARUSO Bought 8,680 shares of Cellectar Biosciences on May 11, 2026 for an estimated value of $25.00K.

JAMES V CARUSO's Trading History

CLRB
Cellectar Biosciences
May 11, 2026President & CEO, DirectorInformative Buy25.00K$24.48K
CLRB
Insider Shares: 20.32K (0.48%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 11, 2026Informative Buy$25.00K8,680$2.88-60.60%
Jul 03, 2025Informative Buy$49.90K10,000$4.99-41.40%
Dec 12, 2023Uninformative Buy$0.0040,596$0.00―
Mar 05, 2021Informative Buy$8.62K5,100$1.69-72.80%
Dec 28, 2020Informative Buy$50.00K37,037$1.35-66.10%

You May Also Like

JAMES V CARUSO insider profile FAQ

What is the percentage of profitable transactions made by JAMES V CARUSO?
The percentage of profitable transactions made by JAMES V CARUSO is 20%.
What is the average return per transaction made by JAMES V CARUSO?
The average return per transaction made by JAMES V CARUSO is -47.00%.
What stocks does JAMES V CARUSO hold?
JAMES V CARUSO holds: CLRB stocks.
What was JAMES V CARUSO’s latest transaction?
JAMES V CARUSO’s latest transaction was an Informative Buy of $25.00K.
What was JAMES V CARUSO's most profitable transaction?
JAMES V CARUSO’s most profitable transaction was an Informative Buy of CLRB stock on June 8, 2020. The return on the trade was 28.80%.
What is JAMES V CARUSO's role in Cellectar Biosciences?
JAMES V CARUSO's role in Cellectar Biosciences is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.